Affymetrix Target to Market Genomics in the Pharma Pipeline
Join us for a complimentary lunch seminar to learn how genomic data can help inform your decision-making.
• Participate in sessions on Biomarker Discovery, Toxicogenomics and Pharmacogenomics
• Listen to local thought leaders from Merck-Serono, Novartis, Eli Lilly, CIT, Almac, Oncotest, and Affymetrix
• Discuss key issues with your pharma and biotech colleagues
• Take advantage of volume-based pricing for your toxicology pilot studies–up to 50% off
CLICK A CITY TO VEW LOCAL AGENDA (or visit www.microarraybulletin.com/eupharma07)
BERLIN :: JUNE 5   BASEL :: JUNE 6   BRUXELLES :: JUNE 7   CAMBRIDGE :: JUNE 8

BERLIN :: June 5, 2007
Hotel Berlin Hilton :: Salon Humboldt :: 11am – 1pm (lunch will follow)
REGISTER

SESSION 1 :: 11am
Biomarker and Target Discovery/Validation

Gene Expression Signature Defines Burkitt’s Lymphoma
Michael Hummel, Ph.D.
Charite-Universitätsmedizin
Berlin, Germany

Profiling RNA from FFPE Samples with Standard Affymetrix Arrays
Tarif Awad, Ph.D.
Sr. Manager, Cancer Biomarkers
Affymetrix Inc.

SESSION 2 :: 11:45am
Accelerating Toxicology Decisions

Generating Comprehensive Toxicity Profiles using Genomic Data: a ToxFX™ case study
Philippe Ancian, Ph.D.
Head, Functional Genomics
CIT

Rapid Compound Prioritization Using Toxicogenomics
Nigel Skinner, Ph.D.
Sr. Manager, Toxicogenomics
Affymetrix Inc.

SESSION 3 :: 12:25pm
Clinical Trial Patient Stratification

Pharmacogenomics and Tailored Therapies: implications for drug development
Richard Deane Hockett, MD
Director of Genomic Medicine
Eli Lilly

Patient Stratification using Focused and Whole-genome Genotyping Microarrays
Minna Satchi, Ph.D.
Manager, Pharmacogenomics
Affymetrix Inc.
Complimentary lunch and discussion following seminars at 1:00pm
REGISTER today to reserve your spot
Click to view agenda below Click to view agenda below Click to view agenda below Click to view agenda below